Skip to Main Content

Paper Details

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
Lancet Infect Dis
120
2023
Author NameAffiliation
Cheryl CohenUniversity of the Witwatersrand, Centre for Respiratory Disease and Meningitis at the National Institute for Communicable Diseases, South Africa School of Public Health
James E CroweVanderbilt University Medical Center
Philippe LemeyClinical and Epidemiological Virology, Rega Institute
Octavio RamiloNationwide Children's Hospital Columbus
Daniel M WeinbergerYale School of Public Health Department of Epidemiology of Microbial Diseases, Yale University
  • 1 - 5

Datasets